All Pharma News
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
27 Feb 2024
Share Share
Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review

Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review
GLOBENEWSWIRE
16 Jan 2024
Share Share
Aclaris Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777

Aclaris Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777
GLOBENEWSWIRE
10 Jan 2024
Share Share
Aclaris lays off 46%, resurrects zunsemetinib for cancer

Aclaris lays off 46%, resurrects zunsemetinib for cancer
James Waldron FIERCE BIOTECH
20 Dec 2023
Share Share
Aclaris halves headcount, banks on next mid-stage readout after setbacks

Aclaris halves headcount, banks on next mid-stage readout after setbacks
Amber Tong ENDPTS
19 Dec 2023
Share Share
Aclaris Therapeutics Provides Corporate Update

Aclaris Therapeutics Provides Corporate Update
GLOBENEWSWIRE
19 Dec 2023
Share Share
Aclaris Announces Patent License Agreement with Sun Pharma for Alopecia

Aclaris Announces Patent License Agreement with Sun Pharma for Alopecia
GLOBENEWSWIRE
05 Dec 2023
Share Share
Aclaris Announces Results from 12-Week Phase 2b Trial of Oral Zunsemetinib

Aclaris Announces Results from 12-Week Phase 2b Trial of Oral Zunsemetinib
GLOBENEWSWIRE
13 Nov 2023
Share Share
Aclaris shares plummet on terminating development of rheumatoid arthritis drug

Aclaris shares plummet on terminating development of rheumatoid arthritis drug
REUTERS
13 Nov 2023
Share Share
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results

Aclaris Therapeutics Reports Third Quarter 2023 Financial Results
GLOBENEWSWIRE
06 Nov 2023
Share Share